At Novo Nordisk, we are committed to providing a safe and healthy working environment for all our employees. In order to improve our performance and make health and safety (H&S) an integrated part of our daily work at all levels of the organization we have undergone a major reorganization in Denmark in 1997. Targets set for 1997 were all achieved, including a further 15% reduction in the frequency of occupational injuries and a reduction in the total number of diseases caused by working conditions. |
![]() |
|||||||
Read our Health & Safety Policy |
||||||||
H&S organization restructured in Denmark The ultimate responsibility for a safe working environment lies with line management. However, without the involvement of all employees our ambitious targets will not be achieved. 210 elected H&S representatives are now devoting up to 20% of their time on working environment activities, and five employee representatives are now part of the H&S Committee, which has responsibility for Novo Nordisk's H&S policies and guidelines. An important part of the H&S department's new role after the reorganization is to prepare profiles highlighting H&S issues which may require particular focus in the safety programmes to be set up in each area. |
||||||||
![]() |
||||
Working in enzyme recovery, e.g. at the filter press, requires safety equipment like rubber gloves and a mask to protect against exposure to enzymes. |
||||
RESULTS IN DENMARK IN 1997 Occupational injuries In 1997, 45% of the total number of injuries were due to falls, sprains or blows. 35% were due to the incorrect use of tools and machinery, while 20% were caused by burns, corrosive chemicals or toxic substances. 1995-97 target: A further 15% reduction in the frequency of occupational injuries in Denmark over a three-year period against the 1994 baseline. The target was reached in 1997. The number of occupational injuries in Denmark decreased from 132 in 1994 to 124 in 1997 while the number of employees increased by 10% over the same period. The frequency of occupational injuries per million working hours was 10.8 in 1994 and 1995, 11.3 in 1996 and 9.2 in 1997. The main reason for the significant reduction in 1997 compared to 1996 is believed to be the greater focus on health and safety during the year and the greater responsibility given to line management. Occupational diseases 1997 target: A decrease in the total incidence of occupational diseases. This target has been achieved. The total number of cases decreased from 43 in 1996 to 30 in 1997. Over the same two years, the incidence of occupational diseases has decreased from 3.2 to 2.2 cases per million working hours. Allergy to enzymes Each year at Novo Nordisk a small number of cases of enzyme allergy are found among employees handling enzymes. We have therefore established an allergy monitoring programme designed to prevent enzyme allergies. In 1997 there were nine cases of enzyme allergy, four in production and five in the laboratory area. Since most cases of enzyme allergy in recent years have been found in the laboratory area the working environment here has received greater attention. In coming years we will investigate exposure to enzymes systematically in both production and the laboratories. Allergy to animals used in experiments Monotonous, repetitive work (MRW) 1996-97 target: Undertake an investigation of monotonous, repetitive work at Novo Nordisk in Denmark before mid-1997. A survey to determine how many departments find it relevant and necessary to work with MRW as a H&S issue has been carried out. The investigation came to the conclusion that further focus and initiatives related to MRW are necessary in several areas at Novo Nordisk. Plans to reduce health risks will be prepared and implemented in the relevant departments as part of a joint effort between management, H&S representatives and the H&S department. The future activities in this focus area will depend on the extent of the problems in the workplace and the priority given to these activities by individual departments. H&S profiles, including specific guidelines, will be prepared and in 1998 there will be greater focus on ergonomics in the workplace. Tooth enamel survey New health and safety targets New 1998 target: Maintain the positive progress made in 1997 and ensure that there is no increase in the number of occupational injuries and diseases. Rehabilitation It is Novo Nordisk's policy that these people should, if possible, stay as employees of Novo Nordisk. Cases are normally resolved by keeping the person in the same job (approx. 45%), retraining (approx. 5%) or, if an employee cannot stay in his or her current job, by early retirement (approx. 43%). Under Novo Nordisk's policy a person entitled to rehabilitation should be given first priority before an outside applicant for all new jobs advertised by the company. Any necessary retraining will furthermore be paid for by the company. In 1997, 93 new rehabilitation cases were reported. As in previous years, musculo-skeletal disorders such as neck, shoulder and back problems accounted for the majority of cases requiring rehabilitation. 60% of the cases reported in 1997 have now been concluded and the tendency is that fewer people are obliged to apply for early retirement and more are able to maintain their current employment or retrain for another job within the organization. Experience in Franklinton As in Denmark, employees exposed to enzymes are monitored regularly to see whether they have become sensitized to enzymes, the stage before they start to show allergic symptoms. A blood test is taken every 12 months. If the employee has grown sensitive to one of the enzymes during that time, he or she will be closely monitored with allergy tests at more frequent intervals. The employee will also be advised by an allergist who looks at his or her allergy history and makes recommendations. The person will only be transferred to another job in the organization as a last resort or at his or her own request. |
||
![]() |
||
"We want to focus on the work problem, not on the people. Our policy is to try to control the exposure at the workplace and if an employee does become sensitized to enzymes, we try to keep them in their jobs as long as possible." |
||
Number of employees, total number of injuries and injury frequency |
||||
Development in the incidence of reported occupational diseases at Novo Nordisk in Denmark |
||||
Reported occupational diseases and injuries per million working hours in Denmark |
||||
Percentage of employees involved in rehabilitation cases in Denmark |
||||
Bioethics report |
||||